Stocksigma LogoStocksigma Logo

Fermenta Biotech Reports H1FY27 Financial Results

Fermenta Biotech reported H1FY27 consolidated revenue of INR 261.9 crore (down 7% YoY), EBITDA of INR 45.6 crore (down 34% YoY), and PAT of INR 18.9 crore

Fermenta Biotech Reports H1FY27 Financial Results

Fermenta Biotech Ltd 路 Press Release 路 05 Nov 2026, 7:18 pm

Fermenta Biotech Reports H1FY27 Financial Results Fermenta Biotech reported H1FY27 consolidated revenue of INR 261.9 crore (down 7% YoY), EBITDA of INR 45.6 crore (down 34% YoY), and PAT of INR 18.9 crore (down 52% YoY). The decline was primarily driven by lower animal nutrition pricing, where sales dropped 52% YoY to INR 22.1 crore, alongside a high base with prior one-offs. Conversely, Human Nutrition grew 2% YoY to INR 162.5 crore, forming nearly two-thirds of revenue. The India market expanded to 51% of total revenue.

Original exchange filing (PDF)

More announcements from Fermenta Biotech Ltd

All Fermenta Biotech Ltd announcements